Specialized Tools: Genomenon

Genomenon — Expert-Curated Clinical & Cancer Literature

Integration with Genomenon's Mastermind database for variant-level literature evidence. Access curated gene–disease and variant–disease associations to support confident clinical decisions.

27M+ Indexed Variants
ACMG/AMP Aligned

A genomic literature database is the backbone of clinical variant interpretation, providing the historical and peer-reviewed context necessary to classify variants with confidence. As the volume of genomic literature grows exponentially, manual searching across multiple journals and databases becomes a bottleneck for clinical throughput.

Golden Helix integrates Genomenon’s Mastermind and Cancer Knowledgebase (CKB) directly into the VarSeq analysis environment. This integration eliminates the need to switch between tools, allowing clinical teams to access variant literature evidence and curated variant database insights alongside their sequencing data.

Whether diagnosing rare inherited conditions or identifying targeted oncology treatments, the combination of VarSeq and Genomenon delivers high-confidence insights into variant pathogenicity, gene-disease association, and therapeutic relevance within a unified interpretation workflow.

Mastermind Genomic Intelligence

Mastermind accelerates interpretation by indexing over 27 million variants across the global literature. Users gain access to expertly curated content aligned with ACMG standards.

  • Comprehensive Coverage: Billions of data points across millions of variants, far exceeding public sources.
  • Evidence-Backed Insights: Direct links to literature for pathogenicity, phenotypic associations, and diagnostic criteria.
  • Consistent Classifications: Harmonize curated content with public databases to produce defensible clinical reports.

Genomenon Cancer Knowledgebase

The Cancer Knowledgebase (CKB) offers oncology-specific curation, linking variants to therapies, trials, and prognostic relevance.

  • Actionable Oncology: Quickly identify targeted therapies and relevant clinical trials for somatic findings.
  • Precision Medicine: Connect genomic alterations directly to FDA-approved therapies and companion diagnostics.
  • Expert Curation: Continuously updated by oncology experts to ensure decisions are guided by current cancer insights.

Benefits of Premium Curated Evidence

Faster Turnaround

Reduce manual curation and literature review time significantly through in-platform access to variant evidence.

Diagnostic Yield

Combine Mastermind data with sources like ClinVar to streamline filtering and surface pathogenic variants faster.

Regulatory Compliance

Support regulatory requirements with robust, evidence-supported variant classifications and audit trails.

Somatic Decision Support

Link somatic variants to therapies, trials, and evidence to inform oncology diagnosis and treatment decisions.

Scalable Quality

Maintain speed and accuracy whether processing single cases or running enterprise-scale cancer programs.

Unified Workflow

Single integration point for both germline and somatic evidence, eliminating the need to switch tools.

Unified Interpretation with Genomenon in VarSeq

By integrating Genomenon's curated content directly into the VarSeq Suite, clinical labs can automate evidence assembly and accelerate variant review. The unified annotation engine combines premium sources with public databases for a comprehensive view of every variant.

In-Platform Literature

Search and review literature-backed variant data without leaving your analysis software.

ACMG/AMP Automation

Automate criteria scoring with expert curated classifications from Mastermind and CKB.

Defensible Reports

Generate evidence-supported clinical reports with direct citations to curated literature.

"By integrating Genomenon's Mastermind directly into VarSeq, we've reduced manual literature review time by over 70% while improving our diagnostic yield."

Clinical Laboratory User

Clinical Workflows

Hereditary & Rare Disease

Leverage Mastermind for expert curated classifications and ACMG criteria. Accelerate rare disease diagnosis with instant evidence for candidate variants.

Rare Disease Solutions

Precision Oncology

Use CKB to connect somatic variants with therapies, clinical trials, and literature evidence. Identify targeted treatment strategies rapidly.

Oncology Workflows

Variant Prioritization

Integrate curated evidence into filtering strategies to focus only on variants with existing clinical or functional relevance.

Variant Analysis Details

Frequently Asked Questions

What is included in the Mastermind database?

Mastermind indexes over 27 million germline and somatic variants, providing deep insights into pathogenicity, gene-disease relationships, and phenotypic associations derived from global literature.

How is CKB different from Mastermind?

While Mastermind focus on comprehensive variant-literature evidence, the Cancer Knowledgebase (CKB) is specifically curated for oncology, linking somatic variants directly to therapies, trials, and diagnostic criteria.

Does this integration require an additional subscription?

Yes, the Genomenon Mastermind and CKB integrations are available as premium annotation modules within the VarSeq Suite. Contact our sales team for licensing details.

How often are the databases updated?

Genomenon updates their curated content regularly to include the most recent peer-reviewed publications and clinical trial updates, which are then synced directly into VarSeq.

Evidence & Interpretation Insights

Learn how to leverage expert curated literature to accelerate your clinical interpretation workflows.

Ready to Strengthen Your Variant Evidence?

Join clinical laboratories worldwide using Genomenon Mastermind and CKB integrated with VarSeq for evidence-backed interpretation.

27M+ Indexed Variants
ACMG/AMP Aligned Curation
Therapy & Trial Matching